ValuEngine cut shares of Cyren (NASDAQ:CYRN) from a hold rating to a sell rating in a research note released on Tuesday morning.
Shares of Cyren (NASDAQ CYRN) opened at $2.35 on Tuesday. The company has a quick ratio of 0.96, a current ratio of 0.96 and a debt-to-equity ratio of 0.24. The company has a market capitalization of $117.12, a P/E ratio of -7.83 and a beta of 1.01. Cyren has a 1-year low of $1.35 and a 1-year high of $2.55.
Cyren (NASDAQ:CYRN) last posted its quarterly earnings results on Monday, November 13th. The technology company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.03). The business had revenue of $7.60 million during the quarter, compared to analyst estimates of $7.90 million. Cyren had a negative net margin of 34.47% and a negative return on equity of 38.38%. The firm’s quarterly revenue was down 3.8% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.02) earnings per share. sell-side analysts anticipate that Cyren will post -0.29 earnings per share for the current fiscal year.
WARNING: This article was originally reported by Markets Daily and is owned by of Markets Daily. If you are accessing this article on another publication, it was illegally copied and republished in violation of US & international copyright & trademark law. The original version of this article can be viewed at https://www.themarketsdaily.com/2018/01/13/valuengine-lowers-cyren-cyrn-to-sell.html.
Cyren Ltd is engaged in developing and marketing information security solutions for protecting Web, e-mail and mobile transactions. The Company is a Security-as-a-Service provider of integrated cloud-based security technology solutions that mitigate cyber threats, malware attacks, information leaks, legal liability and productivity loss through the application of cyber intelligence.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Cyren Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyren and related companies with MarketBeat.com's FREE daily email newsletter.